The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation between irAEs and treatment efficacy of anti-PD-1 single agent in patients with recurrent/metastatic head and neck squamous cell carcinoma: A monocentric real-world observational study.
 
Chiara Gottardi
Travel, Accommodations, Expenses - Merck
 
Giuseppe Anile
Consulting or Advisory Role - MSD
Travel, Accommodations, Expenses - Lilly; Molteni Farmaceutici
 
Ilaria Micheletto
Travel, Accommodations, Expenses - Lilly
 
Marco Krengli
No Relationships to Disclose
 
Andrea Luigi Camillo Carobbio
No Relationships to Disclose
 
Badr El Khouzai
No Relationships to Disclose
 
Stefano Taboni
No Relationships to Disclose
 
Greta Pretto
No Relationships to Disclose
 
Valentina Guarneri
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; Merck Serono; MSD; Novartis; Olema Oncology; Pierre Fabre
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Lilly; Menarini Steamline; Novartis; Roche; Zentiva
Research Funding - AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Synthon (Inst)
Expert Testimony - Lilly
Travel, Accommodations, Expenses - AstraZeneca; Gilead/Forty Seven
 
Maria Grazia Ghi
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD